Laurie Toich, Assistant Editor

Top news of the day from across the healthcare landscape.

The approval greatly expands treatment options for rare inherited blood disorder.

L-glutamine powder (Endari) is the first drug approved to treat sickle cell disease in nearly 20 years.

Liraglutide is an injectable prescription drug that may improve glucose in adults with type 2 diabetes.

Use of mHealth grows as healthcare stakeholders invest in technological solutions.

Patients nearing the end of their lives may wish to stop treatment with statins due to side effects.

Horse-riding and rhythm-and-music therapy improved stroke recovery perception among patients.

Prebiotics seen to reduce weight gain among pediatric patients who were overweight or obese.

Top news of the day from across the healthcare landscape.

Lesinurad plus febuxostat provides dual mechanisms of action to lower urate levels for patients with tophaceous gout.

Glutamine supplement observed to reduce herpes reactivation in mice and guinea pigs.

Some hair care products may cause increased cancer risk.

More than half of workers surveyed do not have access to first aid, CPR, or AED training.

A new study looks into a potential link between hair care and breast cancer incidence.

Top news of the day from across the healthcare landscape.

Scientists develop new drug discovery method that validates investigational cryptosporidiosis drug.

Waiting to get treatment for breast cancer results is worse survival outcomes.

Common type of stroke can increase desire for alcohol consumption.

Conflicting breast cancer screening recommendations could result in late stage disease.

Top news of the day from across the healthcare landscape.

Reservatrol and grape seed extract found to kill colon cancer cells.

Housing subsidies observed to reduce uninsured rate and the unmet healthcare needs of low-income Americans.

Cankinumab (ACZ885) observed to reduce recurrent cardiovascular events.

Increased global temperatures may lead to high levels of fungus in the air.

A look at the top stories in pharmacy last week.

Universal healthcare can impact spending on prescription drugs.

Avodart (dutsteride) could lead to a higher risk of diabetes, high cholesterol, non-alcoholic fatty liver disease, and erectile dysfunction.

IT-139 downregulates GRP78 and may reduce proliferation in pancreatic cancer cells.

Cardiac arrest rate drops 17% among newly-insured, middle-aged Americans.

Alternative treatment options to control blood glucose level in patients with type 2 diabetes show promise.